Skip to main content
. 2022 Jan 31;11:792024. doi: 10.3389/fonc.2021.792024

Table 2.

Patient clinical characteristics.

Clinical factor Data/p-value
Age p-value = 0.142
Average, Range 54 27 - 81
Gender p-value = 0.348
Male (no.,%) 101 75
Female (no.,%) 34 25
WHO Histologic subtype* p-value = 0.544
Type-1 (no., %) 4 3
Type-2 (no., %) 3 2
Type-3 (no., %) 128 95
T-Stage p-value = 0.133
T1 (no., %) 9 7
T2 (no., %) 9 7
T3 (no., %) 94 70
T4 (no., %) 23 17
N-Stage p-value = 0.146
N0 (no., %) 1 1
N1 (no., %) 22 16
N2 (no., %) 98 73
N3 (no., %) 14 10
Overall stage (7th AJCC) p-value = 0.077
Stage-I (no., %) 1 1
Stage-II (no., %) 7 5
Stage-III (no., %) 92 68
Stage-IVA (no., %) 23 17
Stage-IVB (no., %) 12 9
Initial size of primary tumor (mm3) p-value = 0.341
Average, range 43,482 4,537 - 184,333
Initial size of nodal lesion (mm3) p-value = 0.202
Average, range 31,078 501 - 330,143
Initial total tumor burden
(primary + nodal lesion) (mm3)
p-value = 0.153
Average, range 74,560 7,886 - 438,998
Pre-treatment body weight (kg) p-value = 0.265
Average, range 63 37-102

*WHO histologic subtype of NPC: Type 1: Keratinizing squamous cell carcinoma; Type 2: Non-keratinizing differentiated carcinoma; Type 3: Non-keratinizing undifferentiated carcinoma. AJCC, American Joint Committee on Cancer.